Physician profile
Adeel Rabbani
NPI 1083751374
$1,109.24
in general payments reported to CMS, 2019-2025
18 companies · $185 in 2025
The $185 reported for 2025 was more than what a typical Child & Adolescent Psychiatry provider received nationally (typical 2025 total: $132).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $446 · 2020: $122 · 2021: $289 · 2022: $68.25 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $184.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $313.64 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $137.24 | 2019-2022 | |
| Lemaitre Vascular, INC. | $120.93 | 2025 | Artegraft Vascular Graft |
| Sunovion Pharmaceuticals INC. | $86.89 | 2019 | |
| Neos Therapeutics, Lp | $75.92 | 2019-2021 | |
| Bausch Health US, LLC | $75.22 | 2019-2020 | |
| Neuronetics, INC. | $62.98 | 2019-2025 | Neurostar Tms Therapy System |
| Janssen Pharmaceuticals, INC | $37.41 | 2019-2025 | Spravato |
| Adlon Therapeutics L.P. | $32.14 | 2020-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $27.41 | 2022 | |
| Supernus Pharmaceuticals, INC. | $26.75 | 2022-2025 | Qelbree |
| Ironshore Pharmaceuticals INC. | $20.23 | 2019 | |
| Abbvie INC. | $16.21 | 2021 | |
| Tris Pharma INC | $16.08 | 2019 | |
| Allergan, INC. | $15.65 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $15.53 | 2019 | |
| Alfasigma USA, INC. | $15.21 | 2021 | |
| Lundbeck LLC | $13.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adeel Rabbani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.